Principal Investigator
Christopher Naranjo
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251106
Clinical Trial Summary
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Carlos Bidot
Phone Number
+1 (305) 2438793
Email
cbidot2@miami.edu